IP Library Granted Patent US 7,459,144
Granted Patent B2
US 7,459,144 · App. 11/002,864 · Granted Dec 2, 2008

Process for preparation of MR contrast agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,459,144
App. No.
11/002,864
Granted
Dec 2, 2008
Kind
B2
Abstract

The present invention provides a process for the preparation of an MR contrast agent, said process comprising: i) obtaining a solution in a solvent of a hydrogenatable, unsaturated substrate compound and a catalyst for the hydrogenation of said substrate compound; ii) introducing said solution in droplet form into a chamber containing hydrogen gas (H 2 ) enriched in para-hydrogen (p- 1 H 2 ) and/or ortho-deuterium (o- 2 H 2 ) whereby to hydrogenate said substrate to form a hydrogenated imaging agent; iii) optionally subjecting said hydrogenated imaging agent to a magnetic field having a field strength below earth's ambient field strength; iv) optionally dissolving said imaging agent in an aqueous medium; v) optionally separating said catalyst from the solution of said imaging agent in said aqueous medium; vi) optionally separating said solvent from the solution of said imaging agent in said aqueous medium; and vii) optionally freezing the solution of said imaging agent in said aqueous medium.

Claims (7)

1. A hydrogenation apparatus comprising a hydrogenation chamber having a liquid outlet into a conduit leading to a liquid droplet generator inlet to a solvent removal chamber,

said hydrogenation chamber having a hydrogen inlet and a solution inlet provided with a further liquid droplet generator,

said conduit including a catalyst removal chamber between said hydrogenation chamber and said solvent removal chamber and being provided with a liquid inlet, said solvent removal chamber being provided with a gas outlet and with a liquid outlet.

2. An apparatus of claim 1 , wherein said hydrogenation apparatus is further provided with magnetic shielding such that the magnetic field within at least part of said hydrogenation chamber and/or within at least part of said conduit is <50 μT.

3. An apparatus of claim 2 , wherein said magnetic field is <1 μT.

4. An apparatus of claim 2 An, wherein said magnetic field is <0.1 μT.

5. An apparatus of claim 1 , wherein said conduit is provided with a liquid inlet between said hydrogenation chamber and said catalyst removal chamber.

Assignments (1)
CHANGE OF NAME Recorded Aug 2, 2006
From: AMERSHAM HEALTH AS; NYCOMED IMAGING AS
To: GE HEALTHCARE AS
Reel/Frame 018039/0537 →